Citations for
1CMTM3, MDFI, SSTR2
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer.
Patnaik S, Anupriya.
Front Pharmacol 10:588. doi: 10.3389/fphar.2019.00588. eCollection 2019. Review. 2019
2CDH5, CMTM3
CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I, Louzao-Martinez L, Brandt M, van Dijk CGM, Burgisser P, Zhu C, Kros JM, Duncker DJ, Cheng C.
Arterioscler Thromb Vasc Biol 37(6):1098-1114. doi: 10.1161/ATVBAHA.116.308792. Epub 2017 Apr 20. 2017
3CMTM3, MDFI, SSTR2
DNA methylation of CMTM3, SSTR2, and MDFI genes in colorectal cancer.
Li J, Chen C, Bi X, Zhou C, Huang T, Ni C, Yang P, Chen S, Ye M, Duan S.
Gene 630:1-7. doi: 10.1016/j.gene.2017.07.082. Epub 2017 Aug 4. 2017
4CMTM3
Chemokine-like factor-like MARVEL transmembrane domain-containing 3 expression is associated with a favorable prognosis in esophageal squamous cell carcinoma.
Han T, Shu T, Dong S, Li P, Li W, Liu D, Qi R, Zhang S, Zhang L.
Oncol Lett 13(5):2982-2988. doi: 10.3892/ol.2017.5837. Epub 2017 Mar 10. 2017
5CMTM3
Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients.
Shen Z, Chen X, Li Q, Zhou C, Xu Y, Yu R, Ye H, Li J, Duan S.
Clin Biochem 49(16-17):1278-1282. doi: 10.1016/j.clinbiochem.2016.08.002. Epub 2016 Aug 10. 2016
6CMTM3
CMTM3 presents a secreted form released via exosomes.
Liu B, Li H, Fu W, Cheng Y, Yuan W, Liu W, Xue H, Mo X.
Acta Biochim Biophys Sin (Shanghai) 48(6):584-6. doi: 10.1093/abbs/gmw029. Epub 2016 Apr 28. No abstract available. 2016
7CMTM3
CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
Hu F, Yuan W, Wang X, Sheng Z, Yuan Y, Qin C, He C, Xu T.
Clin Transl Oncol 17(8):632-9. doi: 10.1007/s12094-015-1288-9. Epub 2015 May 20. 2015
8CMTM3
CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H, Zhang J, Nan X, Li X, Qu J, Hong Y, Sun L, Chen Y, Li T.
Tumour Biol 36(10):7849-58. doi: 10.1007/s13277-015-3504-1. Epub 2015 May 7. 2015
9CMTM3
CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer.
Su Y, Lin Y, Zhang L, Liu B, Yuan W, Mo X, Wang X, Li H, Xing X, Cheng X, Dong B, Hu Y, Du H, Zhu Y, Ding N, Li J, Liu W, Ma Y, Qiu X, Ji J, Han W.
Cancer Sci 105(1):26-34. doi: 10.1111/cas.12304. Epub 2013 Nov 28. 2014
10CMTM3
CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.
Xie J, Yuan Y, Liu Z, Xiao Y, Zhang X, Qin C, Sheng Z, Xu T, Wang X.
Clin Transl Oncol 16(4):402-9. doi: 10.1007/s12094-013-1092-3. Epub 2013 Aug 2. 2014
11CMTM3, KLK3
CMTM3 can affect the transcription activity of androgen receptor and inhibit the expression level of PSA in LNCaP cells.
Wang Y, Li T, Qiu X, Mo X, Zhang Y, Song Q, Ma D, Han W.
Biochem Biophys Res Commun 371(1):54-8. Epub 2008 Apr 8. 2008
12CMTM1, CMTM2, CMTM3, CMTM4, CMTM5, CMTM6, CMTM7, CMTM8
Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation.
Han W, Ding P, Xu M, Wang L, Rui M, Shi S, Liu Y, Zheng Y, Chen Y, Yang T, Ma D.
Genomics 81(6):609-17. 2003